Neomycin Sulfate recalls
Neomycin Sulfate products have been recalled 2 times, most recently on 7 Sep 2022. The recalling company is usually Cardinal Health. The most common reason is foreign material.
Total recalls2since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 7 Sep 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why neomycin sulfate is recalled
Companies
By year
All neomycin sulfate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Neomycin Sulfate Tablets, USP 500 mg recalledNeomycin Sulfate | Teva Pharmaceuticals USA | Foreign Material | Nationwide |
| Drug | CLASS II | Neomycin Sulf Tablets, USP, 500mg recalled by Cardinal HealthNeomycin Sulfate | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.